Exercise of subscription or conversion rights (domestic)
| Company | Marinomed Biotech AG |
|---|---|
| ISIN | ATMARINOMED6 |
| from1 | 1,480,160 |
| by1 | 3,684 |
| to1 | 1,483,844 |
| Date | 01/10/2022 |
| Market | Official Market |
| Market segment | prime market |
| Company | Immofinanz AG |
| ISIN | AT0000A21KS2 |
| from1 | 123,293,795 |
| by1 | 14,963,965 |
| to1 | 138,257,760 |
| Date | 01/24/2022 |
| Market | Official Market |
| Market segment | prime market |
| Company | Marinomed Biotech AG |
| ISIN | ATMARINOMED6 |
| from1 | 1,484,706 |
| by1 | 3,623 |
| to1 | 1,488,329 |
| Date | 02/15/2022 |
| Market | Official Market |
| Market segment | prime market |
| Company | Immofinanz AG |
| ISIN | AT0000A21KS2 |
| from1 | 138,257,760 |
| by1 | 24,232 |
| to1 | 138,281,992 |
| Date | 03/17/2022 |
| Market | Official Market |
| Market segment | prime market |
| Company | Marinomed Biotech AG |
| ISIN | ATMARINOMED6 |
| from1 | 1,488,329 |
| by1 | 3,950 |
| to1 | 1,492,279 |
| Date | 03/23/2022 |
| Market | Official Market |
| Market segment | prime market |
| Company | Immofinanz AG |
| ISIN | AT0000A21KS2 |
| from1 | 138,281,992 |
| by1 | 72,698 |
| to1 | 138,354,690 |
| Date | 04/08/2022 |
| Market | Official Market |
| Market segment | prime market |
| Company | Immofinanz AG |
| ISIN | AT0000A21KS2 |
| from1 | 138,354,690 |
| by1 | 261,712 |
| to1 | 138,616,402 |
| Date | 04/29/2022 |
| Market | Official Market |
| Market segment | prime market |
| Company | Marinomed Biotech AG |
| ISIN | ATMARINOMED6 |
| from1 | 1,492,279 |
| by1 | 4,008 |
| to1 | 1,496,287 |
| Date | 05/02/2022 |
| Market | Official Market |
| Market segment | prime market |
Overview of Corporate Actions
Capital increases
Stock splits and reverse stock splits
Capital decreases
Capital adjustments